Citation Impact
Citing Papers
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
2013 StandoutNobel
Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite
2005 Science
Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of T H 17 to Regulatory T Cells in HIV Disease
2010
CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells
2008 StandoutNobel
The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor ζ-Chain and Induce a Regulatory Phenotype in Naive T Cells
2006
An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
2010
CD4+ Tregs and immune control
2004 StandoutNobel
Induction of Indoleamine 2,3-Dioxygenase in Vascular Smooth Muscle Cells by Interferon-γ Contributes to Medial Immunoprivilege
2007
Constitutive Expression of IDO by Dendritic Cells of Mesenteric Lymph Nodes: Functional Involvement of the CTLA-4/B7 and CCL22/CCR4 Interactions
2009 StandoutNobel
Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation
2015 StandoutNobel
Treml4, an Ig Superfamily Member, Mediates Presentation of Several Antigens to T Cells In Vivo, Including Protective Immunity to HER2 Protein
2011 StandoutNobel
The IDO–AhR Axis Controls Th17/Treg Immunity in a Pulmonary Model of Fungal Infection
2017
Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction
2003
Dendritic Cells: Translating Innate to Adaptive Immunity
2006 StandoutNobel
Regulatory T cells in transplantation
2002
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase
2004
Indoleamine 2,3-dioxygenase–expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection
2006
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
IDO-expressing regulatory dendritic cells in cancer and chronic infection
2007
Inhibition of human herpes simplex virus type 2 by interferon γ and tumor necrosis factor α is mediated by indoleamine 2,3-dioxygenase
2004
The biology and management of non-small cell lung cancer
2018 StandoutNature
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006
Tryptophan metabolites interfere with the Ehrlich reaction used for the measurement of kynurenine
2004
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
2004
IDO and tolerance to tumors
2003
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4
2005 StandoutNobel
TGF-β and kynurenines as the key to infectious tolerance
2009
The changing landscape of atherosclerosis
2021 StandoutNature
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice
2014
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Identification of Cinnabarinic Acid as a Novel Endogenous Aryl Hydrocarbon Receptor Ligand That Drives IL-22 Production
2014
IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive
2011
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
2009
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
2005 StandoutNobel
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
2006 StandoutNobel
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Tolerance, DCs and tryptophan: much ado about IDO
2003
An IFN-γ-IL-18 Signaling Loop Accelerates Memory CD8+ T Cell Proliferation
2008 StandoutNobel
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
2014
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer
2013
Role of the Kynurenine Metabolism Pathway in Inflammation-Induced Depression: Preclinical Approaches
2016
Tryptophan metabolism: entering the field of aging and age-related pathologies
2013
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Antimicrobial and immunoregulatory properties of human tryptophan 2,3‐dioxygenase
2009
Tryptophan degradation in autoimmune diseases
2007
Dioxin and immune regulation
2010
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
2013 Standout
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages
2007 StandoutNobel
Suppression of Th1 differentiation by tryptophan supplementation in vivo
2017
4-1BB-mediated immunotherapy of rheumatoid arthritis
2004
The kynurenine pathway of tryptophan degradation as a drug target
2003
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
2007
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis
2017
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Indoleamine 2,3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis
2014
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy
2015
Inhibition of experimental asthma by indoleamine 2,3-dioxygenase
2004
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma
2009
CDllc + Cells Modulate Pulmonary Immune Responses by Production of Indoleamine 2,3-Dioxygenase
2003
Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development
2015
Indoleamine 2,3-dioxygenase–expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells
2009
Role of indoleamine 2,3-dioxygenase in health and disease
2015
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
2004 Standout
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality
2009
Dendritic cells with TGF-β1 differentiate naïve CD4+CD25−T cells into islet-protective Foxp3+regulatory T cells
2007 StandoutNobel
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
2012
The end of the road for the tryptophan depletion concept in pregnancy and infection
2016
The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function
2006
Discovery of IDO1 Inhibitors: From Bench to Bedside
2017
Kynurenine Pathway Enzymes in Dendritic Cells Initiate Tolerogenesis in the Absence of Functional IDO
2006
1-Methyl-Tryptophan Can Interfere with TLR Signaling in Dendritic Cells Independently of IDO Activity
2006
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Blockade of IDO Inhibits Nasal Tolerance Induction
2007
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Glucose Availability Regulates IFN-γ Production and p70S6 Kinase Activation in CD8+ Effector T Cells
2005
Role of Indoleamine-2,3-Dioxygenase in Alpha/Beta and Gamma Interferon-Mediated Antiviral Effects against Herpes Simplex Virus Infections
2004
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
2005
Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion
2003
Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells
2003 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Tryptophan and the immune response
2003
Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors
2005
Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells
2004
Indoleamine 2,3-Dioxygenase Is Regulated by IFN-γ in the Mouse Placenta During Listeria monocytogenes Infection
2003
Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells
2005
Toll-Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow-Derived Mesenchymal Stem Cells by Inducing Indoleamine-2,3-dioxygenase-1 via Interferon-β and Protein Kinase R
2009
The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation
2008
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators
2011
CD4+CD25+Foxp3+ T Cells and CD4+CD25−Foxp3+ T Cells in Aged Mice
2006 StandoutNobel
Tolerogenic Dendritic Cells
2003 StandoutNobel
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Indoleamine 2,3-Dioxygenase Mediates Cell Type-Specific Anti-Measles Virus Activity of Gamma Interferon
2005
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Nitric Oxide-Mediated Regulation of Gamma Interferon-Induced Bacteriostasis: Inhibition and Degradation of Human Indoleamine 2,3-Dioxygenase
2004
Analysis of the Underlying Cellular Mechanisms of Anti-CD154-Induced Graft Tolerance: The Interplay of Clonal Anergy and Immune Regulation
2005 StandoutNobel
Works of Lars Röse being referenced
Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells
2002